Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ferrario

Showing results (181-190 of 828) with videos related to

Pageof 83
Sort By:
Current Medical Research and Opinion|July 14, 2000
Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damageJ M Flack, G A Mensah, C M Ferrario
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Hypotensive actions of microinjections of angiotensin II into the dorsal motor nucleus of the vagusD I Diz, K L Barnes, C M Ferrario
Advances in Pharmacology (San Diego, Calif.)|October 12, 2010
Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7)Carlos M Ferrario, Sarfaraz Ahmad, Janae Joyner, et al.
Future Cardiology|October 7, 2009
Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heartE Ann Tallant, Carlos M Ferrario, Patricia E Gallagher
British Journal of Experimental Pathology|August 1, 1980
Experimental benign and malignant hypertension with malignant nephrosclerosisR E Chatelain, P M DiBello, C M Ferrario
Hypertension (Dallas, Tex. : 1979)|September 1, 1982
Effects of chronic sodium depletion on canine brain renin and cathepsin D activitiesK B Brosnihan, R R Smeby, C M Ferrario
Life Sciences|January 1, 1993
A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11W R Welches, K B Brosnihan, C M Ferrario
Clinical Chemistry|September 1, 1996
Angiotensin peptide research overlookedM C Chappell, K B Brosnihan, C M Ferrario
Bibliotheca Cardiologica|January 1, 1989
Assessment of the mechanism of action of antianginal drugs by the continuous thermodilution methodG Specchia, S De Servi, M Ferrario, et al.
Canadian Journal of Physiology and Pharmacology|November 1, 1972
Acceleration of renal hypertension accompanied by increase in plasma volume as a result of prior thoracic sympathectomyJ R Chessar, C M Ferrario, J W McCubbin
Pageof 83

Showing results (181-190 of 828) with videos related to

Sort By:
Pageof 83
Current Medical Research and Opinion|July 14, 2000
Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damageJ M Flack, G A Mensah, C M Ferrario
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Hypotensive actions of microinjections of angiotensin II into the dorsal motor nucleus of the vagusD I Diz, K L Barnes, C M Ferrario
Advances in Pharmacology (San Diego, Calif.)|October 12, 2010
Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7)Carlos M Ferrario, Sarfaraz Ahmad, Janae Joyner, et al.
Future Cardiology|October 7, 2009
Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heartE Ann Tallant, Carlos M Ferrario, Patricia E Gallagher
British Journal of Experimental Pathology|August 1, 1980
Experimental benign and malignant hypertension with malignant nephrosclerosisR E Chatelain, P M DiBello, C M Ferrario
Hypertension (Dallas, Tex. : 1979)|September 1, 1982
Effects of chronic sodium depletion on canine brain renin and cathepsin D activitiesK B Brosnihan, R R Smeby, C M Ferrario
Life Sciences|January 1, 1993
A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11W R Welches, K B Brosnihan, C M Ferrario
Clinical Chemistry|September 1, 1996
Angiotensin peptide research overlookedM C Chappell, K B Brosnihan, C M Ferrario
Bibliotheca Cardiologica|January 1, 1989
Assessment of the mechanism of action of antianginal drugs by the continuous thermodilution methodG Specchia, S De Servi, M Ferrario, et al.
Canadian Journal of Physiology and Pharmacology|November 1, 1972
Acceleration of renal hypertension accompanied by increase in plasma volume as a result of prior thoracic sympathectomyJ R Chessar, C M Ferrario, J W McCubbin
Pageof 83